Cortactin expression: Association with disease progression and survival in oral squamous cell carcinoma.

Dominik HornMadeleine GrossGerhard DyckhoffJennifer FuchsNiels GrabeWilko WeichertEsther HerpelChristel Herold-MendePeter LichterJürgen HoffmannJochen HessKolja Freier

Published in: Head & neck (2018)

We propose CTTN for managing OSCC in terms of adjuvant therapy and aftercare. Furthermore, our study reveals new potential targets in CTTN signaling for individualized OSCC therapy.

Keyphrases

poor prognosis
risk assessment
human health
cell therapy
chemotherapy induced